Security key
52886X107
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 23,119,889
- Total 13F value
- $361,545,010
- Share change
- +6,940,097
- SEC-reported price per share
- $15.68
- Number of holders
- 54
- Value change
- +$108,427,159
- Number of buys
- 44
- Number of sells
- 10
- Shares outstanding
- 79,177,727
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
54
Top holders
10
LXEO full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Lexeo Therapeutics, Inc. SEC filings
Lexeo Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 52886X107
Recent filing periods:
Ownership snapshot
Top reported holders of LXEO - LEXEO THERAPEUTICS INC - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
EVENTIDE ASSET MANAGEMENT...
Disclosed value leader
EVENTIDE ASSET MANAGEMENT...
Comparable rows
15/15
Latest evidence
31 Dec 2023
13F
Lead comparable stake: 3.8%
Showing 1-6 of 15 holder rows.
Quick read
EVENTIDE ASSET MANAGEMENT, LLC leads the comparable SEC ownership view at 3.8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens EVENTIDE ASSET MANAGEMENT, LLC's linked filing trail.
Comparable ownership
Top 5
EVENTIDE ASSET MANAGEMENT, LLC
3.8%
D1 Capital Partners L.P.
3.2%
Janus Henderson Group Ltd.
2.9%
Omega Fund Management, LLC
2.7%
CITADEL ADVISORS LLC
2.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
Company
|
3.8%
|
$40,297,992
3,002,831 shares
|
— | 31 Dec 2023 |
| D1 Capital Partners L.P. |
13F
Company
|
3.2%
|
$33,638,666
2,506,607 shares
|
— | 31 Dec 2023 |
| Janus Henderson Group Ltd. |
13F
Company
|
2.9%
|
$31,305,963
2,330,738 shares
|
— | 31 Dec 2023 |
| Omega Fund Management, LLC |
13F
Company
|
2.7%
|
$28,955,301
2,157,623 shares
|
— | 31 Dec 2023 |
| CITADEL ADVISORS LLC |
13F
Company
|
2.6%
|
$27,970,568
2,084,245 shares
|
— | 31 Dec 2023 |
| Novo Holdings A/S |
13F
Company
|
1.7%
|
$17,551,065
1,307,829 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
54
Shares
23,119,889
Rows available
54
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2024 Across Filers
Q1 2024 holders
54
Q1 2024 holders
54
Holder diff
0
| Investor | Q1 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q1 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend